Immunoglobulins and immunoglobulin subclasses in the elderly

被引:55
作者
Lock, RJ [1 ]
Unsworth, DJ [1 ]
机构
[1] Southmead Gen Hosp, N Bristol NHS Trust, Bristol BS10 5NB, Avon, England
关键词
D O I
10.1258/000456303763046067
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Published data imply that adult concentrations are achieved for all Ig isotypes and plateau by 15-18 years of age. Recent data, however, suggest that these results are not applicable in the elderly. There are no equivalent data for IgG subclasses. We present reference range data for an elderly UK patient population, for IgG, IgA, IgM and IgG subclasses. Methods Serum immunoglobulins were reviewed on samples from 1146 patients > 60 years of age and 925 patients aged 18-60 years. Serum IgG subclasses were reviewed on samples from 498 patients > 60 years and 484 patients aged 18-60 years. All Igs and subclasses were measured by nephelometry. Reference ranges were derived by probability plotting. Results Serum median IgG and IgM concentrations are reduced in the elderly (IgG female P<0.001, IgG male P<0.03; IgM female P<0.001, IgM male P<0.001). Serum IgA concentrations are maintained. Indeed, men showed a slight increase in serum IgA with age (P= 0.03). Few differences dependent on gender were seen. Median IgM was lower in men in the younger age groups (18-60 years P<0.001; 61-70 years P=0.017). IgG, is reduced in elderly men (P=0.002) and IgG(1) reduced in elderly women (P = 0.009). Conclusions We advocate that centres offering these investigations provide local, method-dependent reference ranges, and suggest an approach as to how this might be achieved.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 8 条
[1]   THE QUANTIFICATION OF HUMAN-IGG SUBCLASSES IN REFERENCE PREPARATIONS [J].
KLEIN, F ;
SKVARIL, F ;
VERMEEREN, R ;
VLUG, A ;
DUIMEL, WJ .
CLINICA CHIMICA ACTA, 1985, 150 (02) :119-127
[2]  
MORRELL A, 1972, J IMMUNOL, V108, P195
[3]  
RADL J, 1975, CLIN EXP IMMUNOL, V22, P84
[4]  
Ritchie RF, 1998, J CLIN LAB ANAL, V12, P363, DOI 10.1002/(SICI)1098-2825(1998)12:6<363::AID-JCLA6>3.0.CO
[5]  
2-X
[6]  
TOMER R, 2001, CLIN IMMUNOLOGY PRIN, V2, P2
[7]  
VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561
[8]  
WARD AM, 2001, PRU HDB CLIN IMMUNOC, P213